Li Y - Search Results

1

Bio-inspired engineered ferritin-albumin nanocomplexes for targeted ferroptosis therapy.

Xue C, Zhang H, Wang X, Du H, Lu L, Fei Y, Li Y, Zhang Y, Li M, Luo Z. Xue C, et al. Among authors: li y, li m. J Control Release. 2022 Nov;351:581-596. doi: 10.1016/j.jconrel.2022.09.051. Epub 2022 Sep 30. J Control Release. 2022. PMID: 36181916

2

NIR-Actuated Remote Activation of Ferroptosis in Target Tumor Cells through a Photothermally Responsive Iron-Chelated Biopolymer Nanoplatform.

Xue C, Li M, Liu C, Li Y, Fei Y, Hu Y, Cai K, Zhao Y, Luo Z. Xue C, et al. Among authors: li y, li m. Angew Chem Int Ed Engl. 2021 Apr 12;60(16):8938-8947. doi: 10.1002/anie.202016872. Epub 2021 Mar 8. Angew Chem Int Ed Engl. 2021. PMID: 33543529

3

Tumor-activatable biomineralized nanotherapeutics for integrative glucose starvation and sensitized metformin therapy.

Wen H, Fei Y, Cai R, Yao X, Li Y, Wang X, Xue C, Hu Y, Li M, Luo Z. Wen H, et al. Among authors: li y, li m. Biomaterials. 2021 Nov;278:121165. doi: 10.1016/j.biomaterials.2021.121165. Epub 2021 Oct 9. Biomaterials. 2021. PMID: 34649197

4

An ROS-Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis Therapy.

Zhang Y, Li L, Li Y, Fei Y, Xue C, Yao X, Zhao Y, Wang X, Li M, Luo Z. Zhang Y, et al. Among authors: li y, li m, li l. Adv Healthc Mater. 2022 Jan;11(2):e2101702. doi: 10.1002/adhm.202101702. Epub 2021 Nov 8. Adv Healthc Mater. 2022. PMID: 34710950

5

Cell-Specific Metabolic Reprogramming of Tumors for Bioactivatable Ferroptosis Therapy.

Li Y, Li M, Liu L, Xue C, Fei Y, Wang X, Zhang Y, Cai K, Zhao Y, Luo Z. Li Y, et al. Among authors: li m. ACS Nano. 2022 Mar 22;16(3):3965-3984. doi: 10.1021/acsnano.1c09480. Epub 2022 Feb 24. ACS Nano. 2022. PMID: 35200009

6

Hierarchical integration of degradable mesoporous silica nanoreservoirs and supramolecular dendrimer complex as a general-purpose tumor-targeted biomimetic nanoplatform for gene/small-molecule anticancer drug co-delivery.

Fei Y , Li M , Li Y , Wang X , Xue C , Wu Z , Xu J , Xiazeng Z , Cai KY , Luo Z . Fei Y , et al. Among authors: li y, li m. Nanoscale. 2020 Aug 14;12(30):16102-16112. doi: 10.1039/d0nr03978k. Epub 2020 Jul 29. Nanoscale. 2020. PMID: 32724952

7

A redox-activatable biopolymer-based micelle for sequentially enhanced mitochondria-targeted photodynamic therapy and hypoxia-dependent chemotherapy.

Li Y , Sutrisno L , Hou Y , Fei Y , Xue C , Hu Y , Li M , Luo Z . Li Y , et al. Among authors: li m. Chem Commun (Camb). 2020 Sep 7;56(69):9978-9981. doi: 10.1039/d0cc03667f. Epub 2020 Jul 28. Chem Commun (Camb). 2020. PMID: 32851998

8

Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors.

Zhou J, Xue C, Hou Y, Li M, Hu Y, Chen Q, Li Y, Li K, Song G, Cai K, Luo Z. Zhou J, et al. Among authors: li y, li m, li k. Biomaterials. 2019 Mar;197:129-145. doi: 10.1016/j.biomaterials.2019.01.002. Epub 2019 Jan 4. Biomaterials. 2019. PMID: 30641264

9

Fe₃O₄-based nanotheranostics for magnetic resonance imaging-synergized multifunctional cancer management.

Li Y, Zhang H. Li Y, et al. Nanomedicine (Lond). 2019 Jun;14(11):1493-1512. doi: 10.2217/nnm-2018-0346. Epub 2019 Jun 19. Nanomedicine (Lond). 2019. PMID: 31215317 Review.

10

Nanoparticle-Based Drug Delivery Systems for Enhanced Tumor-Targeting Treatment.

Li Y, Zhang H. Li Y, et al. J Biomed Nanotechnol. 2019 Jan 1;15(1):1-27. doi: 10.1166/jbn.2019.2670. J Biomed Nanotechnol. 2019. PMID: 30480512 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241,218 results

Search Page

Filters